Search Results - Fischer, Sarah

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative ef... by Kohrt, Lisa-Madeleine (Author) , Gladbach, Yvonne S. (Author) , Ernst, M. (Author) , Hamed, M. (Author) , Roolf, C. (Author) , Sender, S. (Author) , Beck, J. (Author) , Schütz, E. (Author) , Fischer, Sarah (Author) , Struckmann, Stephan (Author) , Junghanss, C. (Author) , Fuellen, G. (Author) , Murua Escobar, H. (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188 by Fischer, Sarah Maud (Author) , Parmentier, Johannes (Author) , Reimold, Isolde (Author) , Fricker, Gert (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay by Fischer, Sarah Maud (Author) , Saal, Wiebke (Author) , Fricker, Gert (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4
  5. 5

    In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants by Fischer, Sarah Maud (Author) , Flaten, Gøril Eide (Author) , Hagesæther, Ellen (Author) , Fricker, Gert (Author) , Brandl, Martin (Author) ,


    Get full text
    Article (Journal) Online Resource